title: Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
authors.affiliation: Heart Failure and Transplantation Program, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Sánchez
authors.forename: J F
authors.initials: JF
authors.lastname: Delgado
authors.forename: T
authors.initials: T
authors.lastname: Blasco
authors.forename: R
authors.initials: R
authors.lastname: Dalmau
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: P
authors.initials: P
authors.lastname: Escribano
authors.forename: R
authors.initials: R
authors.lastname: Tello
authors.forename: J
authors.initials: J
authors.lastname: Hernández
authors.forename: T
authors.initials: T
authors.lastname: Velázquez
authors.forename: T
authors.initials: T
authors.lastname: Sotelo
authors.forename: M A
authors.initials: MA
authors.lastname: Gómez-Sánchez
authors.forename: C
authors.initials: C
authors.lastname: Sáenz de la Calzada
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D003327:Coronary Disease / Q000601:surgery; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D008775:Methylprednisolone